bearish

Hugel Inc

Korean Botox Players in Another Round of Patent Fights: Medytox (086900 KS) Sues Hugel (145020 KS)

Medytox has initiated a legal battle against Hugel, accusing Hugel of stealing its botulinum toxin strains and production methods. This may delay Hugel’s plan to enter the U.S. market this year.

Equity Bottom-Up
273 Views, 20 Apr 2022 00:51
SUMMARY
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
  • Unlimited Research Summaries
  • Personalised Alerts
  • Custom Watchlists
  • Company Data & News
  • Events & Webinars
or
Trusted by:
Bloomberg
Societe Generale
SGX
Sequoia
Interactive Broker
Refinitiv
Already have an account? Sign In Now

Discussions
(Paid Plans Only)
WHAT’S TRENDING
Insights
  • Trending
  • Latest
Logo
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Health CareEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Medy Tox Inc (086900 KS): Legal Battle Continues; Muted Recovery in Export Revenue
    06 Jul 2022
  • Korean Botox Players in Another Round of Patent Fights: Medytox (086900 KS) Sues Hugel (145020 KS)
    20 Apr 2022
  • The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?
    15 Aug 2021
  • Hugel Placement: A 5.2% Block Deal Sale
    29 Jun 2020
  • Daewoong: Entering "Botox World"
    28 Mar 2019
x